Summary
Although estimation of serum alpha-fetoprotein (AFP) is widely used in the diagnosis of hepatocellular carcinoma (HCC) and non-seminomatous germ cell tumours (NSGCT), the clinical usefulness of this test is limited by a low specificity. However, there exist glycoforms of AFP which may be more specific for particular tumours. Previously, detailed analysis has been prevented by the low levels of AFP in human serum. We report here the application of fluorescence labelling, sequential exoglycosidase digestion, high-performance liquid chromatography and matrix-assisted laser desorption ionization in time-of-flight mass spectrometry, to determine the glycan structures of purified serum AFP from patients with HCC and NSGCT. Eleven major glycans were found, of which seven were N-linked, and four were O-linked, to the protein backbone. The structure of the N-linked glycans (all of bi-antennary complex-type with varying degrees of sialylation, fucosylation and galactosylation) were consistent with those previously reported. The O-linked glycans (three mucin O-GalNAc type glycans with variable degrees of sialylation, one O-HexNAc monosaccharide glycan) have not previously been reported. The finding of mucin O-GalNAc type glycans was supported by the prediction of potential O-GalNAc glycosylation sites on the protein backbone by analysis of the AFP structure by molecular modelling. With knowledge of these structures it may be possible to develop more specific assays for the detection of HCC and NSGCT. © 1999 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alpert, E, Drysdale, JW, Isselbacher, KJ & Schur, PH (1972). Human α-fetoprotein: isolation, characterization, and demonstration of microheterogeneity. J Biol Chem 247: 3792–3798.
Aoyagi, Y, Suzuki, Y, Igarashi, K, Saitoh, A, Oguro, M, Yokota, T, Mori, S, Nomoto, M, Isemura, M & Asakura, H (1991). The usefulness of simultaneous determinations of glycosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 67: 2390–2394.
Bigge, JC, Patel, TP, Bruce, JA, Goulding, PN, Charles, SM & Parekh, RB (1995). Non-selective and efficient fluorescent labelling of glycans using 2-aminobenzamide and anthranilic acid. Anal Biochem 230: 229–238.
Buamah, PK, Harris, R, James, OFW & Skillen, AW (1986). Lentil-lectin-reactive alpha-fetoprotein in the differential diagnosis of benign and malignant liver disease. Clin Chem 32: 2083–2084.
Burditt, LJ, Johnson, MM, Johnson, PJ & Williams, R (1994). Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing. Cancer 74: 25–29.
Du, MQ, Hutchinson, WL, Johnson, PJ & Williams, R (1991). Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Cancer 67: 476–480.
Elhammer, AP, Poorman, RA & Kezdy, FJ (1997). Predicting mucin-type O-glycosylation sites. In:Techniques in Glycobiology, Townsend RR Hotchkiss AT Marcel Dekker: New York 271–288.
Ferranti, P, Pucci, P, Marino, G, Fiume, I, Terrana, B, Ceccarini, C & Malorni, A (1995). Human α-fetoprotein produced from Hep G2 cell line: structure and heterogeneity of the oligosaccharide moiety. J Mass Spect 30: 632–638.
Hansen, JE, Lund, O, Engelbrecht, J, Bohr, H, Nielsen, JO, Hansen, J-ES & Brunak, S (1995). Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:-polypeptide N-acetylgalactosaminyl transferase. Biochem J 308: 801–813.
Hansen, JE, Lund, O, Tolstrup, N, Gooley, AA, Williams, KL & Brunak, S (1998). NetOglyc: Prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconjugate J 15: 115–130.
Ho, S, Cheng, P, Chan, A, Leung, N, Yeo, W, Leung, T, Lau, WY, Li, AKC & Johnson, PJ (1996). Isoelectric focusing of alpha-fetoprotein in patients with hepatocellular carcinoma – frequency of specific banding patterns at non-diagnostic serum levels. Br J Cancer 73: 985–988.
Javadpour, N (1980). The role of biologic tumour markers in testicular cancer. Cancer 45: 1755–1761.
Johnson, PJ & Williams, R (1987). Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 4: 140–147.
Johnson, PJ, Portmann, B & Williams, R (1978). Alpha-fetoprotein concentration measured by radioimmunoassay in the diagnosing and excluding of hepatocellular carcinoma. Br Med J 2: 661–663.
Johnson, PJ, Ho, S, Cheng, P, Chan, A, Leung, T & Yuen, J (1995). Germ cell tumours express a specific alpha-fetoprotein variant detectable by isoelectric focusing. Cancer 75: 1663–1668.
Johnson, PJ, Leung, N, Cheng, P, Welby, C, Leung, T, Lau, WY & Ho, S (1997). ‘Hepatoma-specific’ alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br J Cancer 75: 236–240.
Kay, PH, Wells, FC & Goldstraw, P (1987). A multi-disciplinary approach to primary nonseminomatous germ cell tumours of the mediastinum. Ann Thorac Surg 44: 578–582.
Kew, MC & Popper, H (1984). Relationship between hepatocellular carcinoma and cirrhosis. Sem Liver Dis 4: 136–146.
Lange, PH & Fralay, EE (1977). Serum AFP and HCG in the treatment of patients with testicular tumours. Urol Clin North Am 4: 393–406.
Lok, ASF & Lai, CL (1989). Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 9: 110–115.
Nichols, CR, Saxman, S, Williams, SD, Loehrer, PJ, Miller, ME, Wright, C & Einhorn, LH (1990). Primary mediastinal nonseminomatous germ cell tumours. A modern single institution experience. Cancer 65: 1641–1646.
Nomura, F, Ohnishi, K & Tanabe, Y (1989). Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Cancer 64: 1700–1707.
Okuda, K (1986). Early recognition of hepatocellular carcinoma. Hepatology 6: 729–738.
Patel, TP, Bruce, JA, Merry, A, Wormald, M & Parekh, RB (1993). The use of hydrazine to release intact and unreduced form both N- and O-linked oligosaccharides from glycoproteins. Biochemistry 32: 679–693.
Sheu, JC, Sung, JL, Chen, DS, Yang, PM, Lai, MY, Lee, CS, Hsu, HC, Chuang, CN, Yang, PC & Wang, TH et al (1985). Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterol 89: 259–266.
Shimizu, K, Katoh, H, Yamashita, F, Tanaka, M, Tanikawa, K, Taketa, K, Satomura, S & Matsuura, S (1996). Comparison of carbohydrate structures for serum α-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis. Clin Chim Acta 254: 23–40.
Smith, CJP & Kelleher, PC (1980). Alpha-fetoprotein molecular heterogeneity: physiologic correlations with normal growth, carcinogenesis and tumour growth. Biochim Biophys Acta 605: 1–31.
Taketa, K, Endo, Y, Sekiya, C, Tanikawa, K, Koji, T, Satomura, S, Matsuua, S, Kawai, T & Hirai, H (1993). A collaborative study for the elevation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 53: 5419–5423.
Tarelli, E, Ashcroft, AE, Calam, DH, Corran, PH, Green, BN & Wheeler, SF (1992). Human alpha-fetoprotein. Molecular weight data from electrospray mass spectrometry (ESMS) analysis. Biol Mass Spect 23: 315–317.
Yamashita, K, Hitoi, A, Tsuchida, Y, Nishi, S & Kobata, A (1983). Sugar chain of alpha-fetoprotein produced in human yolk sac tumour. Cancer Res 43: 4691–4695.
Yamashita, K, Taketa, K, Nishi, S, Fukushima, K & Takashi, O (1993). Sugar chains of human cord serum α-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. Cancer Res 53: 2970–2975.
Yoshima, H, Mizuochi, T, Ishii, M & Kobata, A (1980). Structure of the asparagine-linked sugar chains of α-fetoprotein purified from human ascites fluid. Cancer Res 40: 4276–4281.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Johnson, P., Poon, T., Hjelm, N. et al. Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour. Br J Cancer 81, 1188–1195 (1999). https://doi.org/10.1038/sj.bjc.6690828
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690828
Keywords
This article is cited by
-
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer (2015)
-
The sweet and sour of serological glycoprotein tumor biomarker quantification
BMC Medicine (2013)
-
The Potentials of Glycomics in Biomarker Discovery
Clinical Proteomics (2008)
-
Identification of N-glycan of alpha-fetoprotein by lectin affinity microarray
Journal of Cancer Research and Clinical Oncology (2008)
